Clinical Trials for the Treatment of Sepsis

XXXI, 406 Seiten
1995
Springer Berlin (Hersteller)
978-3-540-58380-6 (ISBN)

Lese- und Medienproben

96,65 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
This overview of the epidemiology, monitoring and treatment of sepsis provides a detailed review of the research literature, recommendations for the monitoring and treatment of sepsis patients, and an outline of the design of future clinical trials.
The incidence of sepsis is increasing as new medical and surgical technologies are applied to an ageing patient population. The treatment of sepsis emphasizes strategies to avoid multiple organ dysfunction, with particular attention to establishing source control, and then modifies the host's response to the excessive inflammatory response which characterizes sepsis. This is a comprehensive review of the epidemiology, monitoring and treatment of sepsis. Using an "evidence-based" approach, it comprises an extensive review of the literature on sepsis, provides up-to-date recommendations for monitoring and treating sepsis patients, and concludes with explicit recommendations for the design and monitoring of future clinical trials.

The "At Risk" Patient Population - ARDS and Sepsis; Measurement of Inflammatory Mediators in Clinical Sepsis; What Determines Prognosis in Sepsis; Evidence-Based Analysis of Nutrition Support in Sepsis; Anti-Endotoxin Therapy; The Monitoring and Reporting of Clinical Trials; Ethical Issues in Clinical Trials.

Reihe/Serie Update in Intensive Care and Emergency Medicine ; 19
Zusatzinfo 61 figs., 74 tabs.
Verlagsort Berlin
Sprache englisch
Gewicht 770 g
Einbandart gebunden
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Mikrobiologie / Infektologie / Reisemedizin
Medizin / Pharmazie Medizinische Fachgebiete Notfallmedizin
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 3-540-58380-7 / 3540583807
ISBN-13 978-3-540-58380-6 / 9783540583806
Zustand Neuware
Haben Sie eine Frage zum Produkt?